SCHEMBL4682936

SCHEMBL4682936

BrC(I)CC1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 2/20 0.32
CYP1A2 P05177 1/20 0.32
ADRA2C P18825 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM1 P11229 1/20 0.32
SIGMAR1 Q99720 1/20 0.30
ADH1B P00325 1/20 0.30
ADH1C P00326 1/20 0.30
ADH1A P07327 1/20 0.30
ADH4 P08319 1/20 0.30
ADH7 P40394 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5068241 0.78 CHRM5 (0.35) CHRM5CYP1A2ADRA2CCHRM2CHRM4
SCHEMBL16933746 0.75
SCHEMBL5906000 0.74 CYP1A2 (0.37) CYP1A2
SCHEMBL14684139 0.74 CYP1A2 (0.37) CYP1A2
SCHEMBL19003165 0.74 CYP1A2 (0.37) CYP1A2
SCHEMBL28930071 0.72 SHBG (0.42) CYP1A2
SCHEMBL16933895 0.72 ALDH1A1 (0.32) CHRM5CYP1A2ADRA2CCHRM2CHRM4
SCHEMBL11021785 0.72 CYP1A2 (0.46) CYP1A2SIGMAR1
SCHEMBL24034904 0.70
SCHEMBL8281787 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1991544-A2 SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE AS PTPASE INHIBITORS Transtech Pharma, Inc. (US) 2008-11-19 EP disclosed
WO-2007089857-A2 SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE AS PTPASE INHIBITORS TRANSTECH PHARMA, INC. (US) 2007-08-09 WO disclosed
EP-1809611-A1 REVERSED PYRIMIDINONE COMPOUNDS AS CALCILYTICS NPS PHARMACEUTICALS, INC. (US) 2007-07-25 EP disclosed
WO-2006041968-A1 REVERSED PYRIMIDINONE COMPOUNDS AS CALCILYTICS NPS PHARMACEUTICALS, INC. (US) 2006-04-20 WO disclosed